Effect of fuzzy partitioning in Crohn's disease classification: a neuro-fuzzy-based approach

Sk Saddam Ahmed1, Nilanjan Dey2, Amira S Ashour3,4

  • 1Department of CSE, JIS College of Engineering, Kalyani, West Bengal, India.

Insights

This study introduces a novel neuro-fuzzy model for diagnosing Crohn's disease (CD), achieving high accuracy. The optimized model demonstrates significant potential for improving diagnostic processes in gastroenterology.

Area of Science:

  • Medical Informatics
  • Artificial Intelligence in Medicine
  • Gastroenterology

Background:

  • Crohn's disease (CD) diagnosis poses significant challenges due to its severe gastrointestinal impact and complex treatment needs.
  • Accurate and early diagnosis of CD is crucial for effective patient management and improving outcomes.
  • Existing diagnostic methods may have limitations in sensitivity, specificity, or efficiency.

Purpose of the Study:

  • To develop and evaluate a hybrid neuro-fuzzy model for enhanced Crohn's disease diagnosis.
  • To investigate the impact of factor analysis for data dimension reduction on diagnostic performance.
  • To determine the optimal fuzzy partitioning level for maximizing classification accuracy.

Main Methods:

  • Utilized a backpropagation neural network fuzzy classifier integrated into a neuro-fuzzy model.
  • Employed factor analysis for dimensionality reduction of the diagnostic dataset.
  • Systematically varied fuzzy partitioning levels to assess their effect on model performance.
  • Evaluated the system using classification accuracy, sensitivity, and specificity.

Main Results:

  • The hybrid neuro-fuzzy model demonstrated high diagnostic performance.
  • Factor analysis and fuzzy partitioning were found to influence system accuracy.
  • Level-8 fuzzy partitioning achieved the highest classification accuracy of 97.67%.
  • The optimal model achieved 96.07% sensitivity and 100% specificity.

Conclusions:

  • The proposed neuro-fuzzy model offers a promising approach for accurate Crohn's disease diagnosis.
  • Optimized data dimension reduction and fuzzy partitioning are key to achieving high diagnostic performance.
  • This AI-driven method has the potential to aid clinicians in diagnosing CD more effectively.

Related Concept Videos

Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.5K
Classification of Illness01:17

Classification of Illness

The meaning of illness is individualized to each person who experiences an alteration in health. In contrast, disease is a medical term indicating a pathological change in the structure and function of the body or mind. It is a condition that has specific symptoms and boundaries.
An illness is a response to a disease in which the person's level of functioning is changed compared with a previous level. The general classification of illness includes acute and chronic.
Acute illness is severe...
9.3K
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
895
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
655
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
1.0K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
722